Dublin, Jan. 13, 2023 (GLOBE NEWSWIRE) -- The "Global Fill Finish Manufacturing Market Size, Share & Industry Trends Analysis Report by End-user, Product, Regional Outlook and Forecast, 2022-2028" ...

The number of biologics and complex drug products entering clinical trials and the market is rising, and many of the active ...

The fill-finish market—a traditionally stable one—is increasingly adopting new technologies. Research from our 12th Annual Report and Survey of Biopharmaceutical Manufacturing, and other studies ...

The 'global fill finish manufacturing market size, share & industry trends analysis report by end-user, product, regional outlook and forecast, 2022-2028' report has been added to ...

SPOKANE, Wash.--(BUSINESS WIRE)--Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological ...

Given the criticality of fill/finish processes, it is clear that automation is the next technological step. All drugs are subjected to regulatory scrutiny during the full development lifecycle because ...

Cell therapies such as CAR-T have revolutionized the biopharmaceutical industry, especially manufacturing processes. As a result, cell therapy developers are always searching for flexible solutions to ...

Despite selecting the right, compendial excipients for a balanced formulation, you may encounter obstacles that delay market deadlines. Learn how to streamline the formulation and fill-finish process ...

The MarketWatch News Department was not involved in the creation of this content. DELRAY BEACH, Fla., Aug. 19, 2025 /PRNewswire/ -- The global Fill Finish Manufacturing Market, valued at US$16.85 ...

—New service ensures rapid delivery of small volume clinical trial materials, solving a critical bottleneck in drug development— SPOKANE, Wash.--(BUSINESS WIRE)--Selkirk Pharma, Inc., a privately held ...